Xultophy 100/3.6
NDC 0169-2911, insulin degludec and liraglutide, injection, solution, from Novo Nordisk.
- Product NDC
- 0169-2911
- Status
- Listed
- Labeler
- Novo Nordisk
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA208583
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2911 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN DEGLUDEC100 [iU]/mL
- LIRAGLUTIDE3.6 mg/mL
Pharmacologic classes
GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0169-2911-15 | 00169291115 | 5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) / 3 mL in 1 SYRINGE, PLASTIC |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/21335fe4-d395-4501-ac2a-2f20d7520da9NADAC price for package 00169291115
GET /v1/drugs/nadac/00169291115
Use it
Look up 0169-2911 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0169-2911 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0169-2911. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.